CIMIT ModelClinical ImpactCommunity: CoLabContact Us
search
Press Releases

CIMIT Investigators Develop New Drug Release Mechanism Utilizing 3-D Superhydrophobic Materials

According to a recent study published in the Journal of the American Chemical Society, this new mechanism uses air as a removable barrier to control the rate at which drug is released

Date: 1/31/2012

According to a recent study, there is a new mechanism of drug release using 3D superhydrophobic materials that utilizes air as a removable barrier to control the rate at which drug is released.

The study was electronically published on January 16, 2012 in the Journal of the American Chemical Society.

Boston University (BU) graduate student Stefan Yohe, under the mentorship of Mark Grinstaff, PhD, BU professor of biomedical engineering and chemistry,  and Yolonda Colson, MD, PhD, director of the Dana-Farber Cancer Institute/Brigham and Women's Hospital (BWH) Cancer Center, prepared drug-loaded superhydrophobic meshes from biocompatible polymers using an electrospinning fabrication method.

By monitoring drug release in aqueous solution and mesh performance in cytotoxicity assays, the team demonstrated that the rate of drug release correlates with the removal of the air pocket within the material, and that the rate of drug release can be maintained over an extended period.

"The ability to control drug release over a 2-3 month period is of significant clinical interest in thoracic surgery with applications in pain management and in the prevention of tumor recurrence after surgical resection," said Colson. Colson is also a thoracic surgeon at BWH with an active practice focused on the treatment of lung cancer patients.

This approach along with the design requirements for creating 3D superhydrophobic drug-loaded materials, the authors write, should facilitate further exploration and evaluation of these drug delivery materials in a variety of cancer and non-cancer applications.

This research was supported by Boston University, Center for Integration of Medicine & Innovative Technology, Coulter Foundation and the National Institutes of Health.

STORY SOURCE

The above story is reprinted materials provided by Brigham and Women's Hospital (BWH). For further information, please contact BWH.

JOURNAL REFERENCE

Stefan T. Yohe, Yolonda L. Colson, Mark W. Grinstaff. Superhydrophobic Materials for Tunable Drug Release: Using Displacement of Air To Control Delivery Rates. Journal of the American Chemical Society, 2012; 120118151911004 DOI: 10.1021/ja211148a

About CIMIT

CIMIT is the Center for Integration of Medicine and Innovative Technology. A non-profit consortium of Boston-area teaching hospitals and engineering schools, CIMIT provides innovators with resources to explore develop and implement novel technological solutions for today’s most urgent healthcare problems.

Members of the consortium are Beth Israel Deaconess Medical Center, Boston Medical Center, Boston University, Brigham and Women's Hospital, The Charles Stark Draper Laboratory, Children's Hospital Boston, Harvard Medical School, Massachusetts General Hospital, Massachusetts Institute of Technology, Newton-Wellesley Hospital, Northeastern University, Partners HealthCare, and VA Boston Healthcare System.

Bookmark and Share

 

Sort recent press releases by topic
of interest:

 

 

Integrated Clinical EnvironmentsNeuroHealth, PTSD & TBI Industry I Foundation Engagement Homebase & Warfighter CareAccelerator

CIMIT does not rate, endorse, recommend or prescribe any products, procedures or services. Subscribe to CIMIT News in RSS

Contact the Webmaster Site Acknowledgements Copyright © 2011 CIMIT. All rights reserved. site map linking policy privacy